Blood Testing Market Trends

ID: MRFR/HC/4341-HCR

200 Pages

Rahul Gotadki

February 2026

Blood Testing Market Research Report: Size, Share, Trend Analysis By Test Type (Complete Blood Count, Blood Chemistry Tests, Blood Glucose Tests, Coagulation Tests, Blood Typing Tests), By End Users (Hospitals, Diagnostic Laboratories, Home Care Settings, Research Institutions), By Product (Reagents, Consumables, Instruments, Software) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Blood Testing Market

The blood testing market is witnessing a significant uptick due to the growing emphasis on preventive healthcare. Consumers are increasingly recognizing the importance of regular blood tests to detect and address potential health issues before they escalate, driving market growth. The market is seeing a lot of new technology, with better ways to find out if something's wrong. This includes using advanced tools and methods in medical care. The arrival of new ways to test blood, like next-generation sequencing and molecular testing is making diagnosis methods more accurate and quicker. The world's growing older people is a big reason for the growth of blood tests market. Old people usually need to check their health often. This means they use a lot of blood tests for finding and handling problems related with getting older. Blood tests are very important for handling long-term illnesses like diabetes, heart problems and cancer. As more people get these diseases all over the world, there's a growing need for regular blood tests to check and catch them early. This is making this market grow. The change to tests done close-by is changing the blood testing world. POCT gives fast and immediate results, cutting down the time to figure out what's wrong. This allows doctors to treat people more quickly. This movement is very important in emergencies and healthcare areas that are far away. People are becoming more aware of their health, so they want complete check-ups. Testing blood is a big part of this process. More and more people are choosing healthier ways of life. This leads them to get regular blood tests for a complete view of their well-being. People are starting to use more types of biomarkers in blood tests. Biomarkers give important clues about many body states and sicknesses, helping doctors to diagnose better. This difference in biomarkers makes blood tests better at finding many kinds of sickness. More and more, the blood testing market is joining forces with digital health platforms. Using digital tools makes it easy for health workers to watch patients from far away, keep their information safe and study it. This helps them better follow the patients' conditions. The time of customized medicine is helping the blood testing market to grow. Blood tests are very important in personal healthcare plans. They give us a lot of information about someone's health to offer them better medical care based on their DNA and specific needs. Regulatory support and the establishment of standardized protocols are playing a pivotal role in the market's development. Governments and healthcare organizations are actively working towards creating a regulatory framework that ensures the reliability and accuracy of blood tests, instilling confidence among consumers and healthcare providers.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

FAQs

What is the current valuation of the Blood Testing Market in 2024?

The Blood Testing Market was valued at 110.49 USD Billion in 2024.

What is the projected market size for the Blood Testing Market by 2035?

The market is projected to reach 236.23 USD Billion by 2035.

What is the expected CAGR for the Blood Testing Market during the forecast period 2025 - 2035?

The expected CAGR for the Blood Testing Market during 2025 - 2035 is 7.15%.

Which companies are considered key players in the Blood Testing Market?

Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific.

What segment generated the highest revenue in the Blood Testing Market in 2024?

Blood Typing Tests generated the highest revenue, valued at 40.49 USD Billion in 2024.

How much is the Blood Chemistry Tests segment projected to grow by 2035?

The Blood Chemistry Tests segment is projected to grow from 25.0 USD Billion in 2024 to 55.0 USD Billion by 2035.

What is the market size for Blood Glucose Tests in 2024?

The Blood Glucose Tests segment was valued at 15.0 USD Billion in 2024.

Which end user segment is expected to see the most growth by 2035?

The Hospitals segment is expected to grow significantly, from 40.0 USD Billion in 2024 to 85.0 USD Billion by 2035.

What is the projected market size for instruments in the Blood Testing Market by 2035?

The Instruments segment is projected to grow from 35.0 USD Billion in 2024 to 80.0 USD Billion by 2035.

How does the market for diagnostic laboratories compare to hospitals in 2024?

In 2024, the Diagnostic Laboratories segment was valued at 30.0 USD Billion, compared to 40.0 USD Billion for Hospitals.

What is the market size for Complete Blood Count tests in 2024?

The market size for Complete Blood Count tests is expected to be 10.05 USD Billion in 2024.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per Market Research Future analysis, the Blood Testing Market Size was estimated at 110.49 USD Billion in 2024. The Blood Testing industry is projected to grow from 118.39 USD Billion in 2025 to 236.23 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.15% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Blood Testing Market is experiencing robust growth driven by technological advancements and a shift towards preventive healthcare.

Technological advancements are revolutionizing blood testing methodologies, enhancing accuracy and efficiency. North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region in blood testing. The Complete Blood Count segment dominates the market, whereas Blood Glucose Tests are witnessing the fastest growth. Rising prevalence of chronic diseases and increasing demand for preventive healthcare are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size	110.49 (USD Billion)
2035 Market Size	236.23 (USD Billion)
CAGR (2025 - 2035)	7.15%
Largest Regional Market Share in 2024	North America

Major Players

Abbott Laboratories (US), <a href="https://diagnostics.roche.com/global/en/products/product-category/lab-type/blood-screening.html">Roche Diagnostics</a> (CH), Siemens Healthineers (DE), Thermo Fisher Scientific (US), Danaher Corporation (US), Becton Dickinson and Company (US), Ortho Clinical Diagnostics (US), Bio-Rad Laboratories (US), Hologic, Inc. (US)

Market Trends

The Blood Testing Market is currently experiencing a transformative phase, driven by advancements in technology and an increasing emphasis on preventive healthcare. Innovations in diagnostic tools and methodologies are enhancing the accuracy and speed of blood tests, which, in turn, is likely to improve patient outcomes. Furthermore, the growing awareness of the importance of regular health check-ups is propelling demand for blood testing services. This trend is particularly evident in emerging economies, where healthcare infrastructure is evolving rapidly, and access to diagnostic services is expanding. As a result, stakeholders in the Blood Testing Market are focusing on developing user-friendly and cost-effective solutions to cater to a broader audience. In addition to technological advancements, regulatory frameworks are also adapting to the changing landscape of the Blood Testing Market. Governments are increasingly prioritizing the establishment of stringent quality standards to ensure the reliability of diagnostic tests. This regulatory focus may lead to enhanced consumer trust and, consequently, increased market growth. Moreover, the integration of artificial intelligence and machine learning into blood testing processes appears to be on the rise, potentially streamlining operations and improving diagnostic accuracy. Overall, the Blood Testing Market is poised for substantial growth, driven by innovation, regulatory support, and a heightened focus on preventive healthcare.

Technological Advancements

The Blood Testing Market is witnessing rapid technological innovations that enhance the precision and efficiency of diagnostic procedures. New methodologies, such as point-of-care testing and automated laboratory systems, are streamlining processes and reducing turnaround times.

Regulatory Developments

Regulatory bodies are increasingly implementing stringent guidelines to ensure the quality and reliability of blood tests. This focus on regulation is likely to foster consumer confidence and promote market expansion.

Shift Towards Preventive Healthcare

There is a growing trend towards preventive healthcare, with individuals becoming more proactive about their health. This shift is driving demand for regular blood testing, as people seek to monitor their health status and detect potential issues early.

Blood Testing Market Market Drivers

Rising Awareness of Blood Disorders

The growing awareness of blood disorders, such as anemia and hemophilia, is driving the Blood Testing Market. Educational campaigns and advocacy efforts are informing the public about the importance of blood health and the need for regular testing. This heightened awareness is leading to an increase in the number of individuals seeking blood tests for diagnosis and monitoring. Furthermore, the prevalence of blood disorders is prompting healthcare providers to recommend routine screenings, thereby boosting the demand for blood testing services. As awareness continues to rise, the Blood Testing Market is likely to experience sustained growth, reflecting the increasing focus on blood health.

Rising Prevalence of Chronic Diseases

The increasing incidence of chronic diseases such as diabetes, cardiovascular disorders, and cancer is a primary driver of the Blood Testing Market. As these conditions require regular monitoring and management, the demand for blood tests has surged. According to recent data, approximately 422 million people worldwide are living with diabetes, necessitating frequent blood glucose testing. This trend is likely to continue, as healthcare providers emphasize early detection and management of chronic diseases. Consequently, the Blood Testing Market is expected to expand significantly, driven by the need for reliable diagnostic tools that facilitate timely interventions and improve patient outcomes.

Growing Demand for Preventive Healthcare

The shift towards preventive healthcare is significantly influencing the Blood Testing Market. As individuals become more health-conscious, there is a rising demand for routine blood tests to monitor health status and detect potential issues early. This trend is supported by initiatives promoting regular health screenings and awareness campaigns about the importance of preventive measures. The market is expected to witness a notable increase in the adoption of blood tests for preventive purposes, with estimates suggesting that the preventive healthcare segment could account for a substantial share of the overall market. This growing focus on prevention is likely to drive the Blood Testing Market forward.

Technological Innovations in Blood Testing

Technological advancements are revolutionizing the Blood Testing Market, leading to more efficient and accurate diagnostic methods. Innovations such as point-of-care testing, microfluidics, and lab-on-a-chip technologies are enhancing the speed and precision of blood tests. For instance, the introduction of portable devices allows for immediate results, which is particularly beneficial in emergency settings. The market for blood testing technologies is projected to grow at a compound annual growth rate of over 6% in the coming years, reflecting the increasing adoption of these advanced solutions. As healthcare systems continue to integrate cutting-edge technologies, the Blood Testing Market is poised for substantial growth.

Increasing Investment in Healthcare Infrastructure

Investment in healthcare infrastructure is a crucial factor propelling the Blood Testing Market. Governments and private entities are allocating significant resources to enhance healthcare facilities, particularly in developing regions. This investment is aimed at improving access to diagnostic services, including blood testing. For example, initiatives to establish more laboratories and diagnostic centers are underway, which will likely increase the availability of blood tests. As healthcare systems expand and modernize, the Blood Testing Market is expected to benefit from improved access and increased testing capabilities, ultimately leading to higher demand for blood testing services.

Market Segment Insights

By Type: Complete Blood Count (Largest) vs. Blood Glucose Tests (Fastest-Growing)

The Blood Testing Market is characterized by a diverse range of types, with Complete Blood Count (CBC) tests holding the largest share due to their extensive use in diagnosing various health conditions. Blood Chemistry Tests and Blood Typing Tests also contribute significantly but are overshadowed by the dominant presence of the CBC segment. Meanwhile, Blood Glucose Tests are emerging as the fastest-growing segment, driven by the rising prevalence of diabetes and the increasing focus on preventive healthcare. In terms of growth trends, technology advancements are enhancing the efficiency and accuracy of Blood Testing Market procedures, paving the way for greater adoption of these tests. The growing awareness of chronic diseases and the importance of early diagnosis are significant drivers propelling Blood Glucose Tests to the forefront. The ongoing innovation in point-of-care testing has further accelerated interest in Blood Chemistry Tests, presenting opportunities for growth in an evolving healthcare landscape.

Complete Blood Count (Dominant) vs. Blood Glucose Tests (Emerging)

Complete Blood Count (CBC) tests represent the backbone of routine diagnostic testing, providing critical information about blood components. This dominance stems from their versatility, being able to identify a wide range of disorders such as anemia, infection, and many other diseases. Conversely, Blood Glucose Tests, while traditionally used for diabetes management, are rapidly gaining traction as the population becomes increasingly health-conscious. The emergence of home monitoring devices and increased healthcare spending are facilitating both segments' growth. While CBC tests are characterized by their comprehensive nature, Blood Glucose Tests are increasingly recognized for their role in proactive health management, making them essential in the modern healthcare framework.

By End User: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing)

In the Blood Testing Market, the distribution of end users illustrates a significant concentration within hospitals, followed closely by diagnostic laboratories. Hospitals comprise the largest segment as they conduct extensive blood tests for a variety of medical conditions, solidifying their status in the market. Diagnostic laboratories also hold a major share as they provide specialized testing services for both hospitals and outpatient clients, contributing richly to the overall market landscape. Meanwhile, home care settings are quickly gaining traction, presenting themselves as a viable alternative for routine blood tests, especially in the wake of increasing demand for patient-centric care.

Hospitals (Dominant) vs. Home Care Settings (Emerging)

Within the Blood Testing Market, hospitals represent the dominant segment, leveraging comprehensive infrastructures that support advanced diagnostic technologies and vast patient volumes. They benefit from established relationships with healthcare providers and often have significant budgets allocated for innovative testing. On the other hand, home care settings are emerging as an important player in the market, driven by the convenience they offer to patients seeking accessible health monitoring solutions. The trend towards home testing is propelled by technological advancements, such as portable blood testing devices and telehealth services, catering to a growing preference for in-home healthcare options.

By Product: Reagents (Largest) vs. Consumables (Fastest-Growing)

In the Blood Testing Market, Reagents dominate the product segment, accounting for the largest share among the various components driving the market. Their critical role in accurate diagnostics positions them as a fundamental aspect within laboratories. In contrast, Consumables are rapidly gaining traction, spurred by the increasing demand for convenient testing solutions. They represent the fastest-growing segment due to their integral use in daily testing procedures and rising emphasis on point-of-care testing.

Reagents (Dominant) vs. Consumables (Emerging)

Reagents are pivotal to the blood testing process, ensuring test accuracy and reliability. They constitute a significant portion of the market share, benefiting from an ever-growing demand for precise diagnostics in healthcare. On the other hand, Consumables are emerging as a crucial aspect of the market, reflecting advancements in testing methodologies and increasing consumer preference for quick and easy testing solutions. As the healthcare industry continues to evolve, the emphasis on Consumables is anticipated to rise, driven by technological innovations and the pressing need for efficient blood testing tools in a rapidly changing landscape.

Get more detailed insights about Blood Testing Market Research Report - Forecast to 2035

Regional Insights

North America : Market Leader in Innovation

North America is the largest market for blood testing, accounting for approximately 45% of the global share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of chronic diseases, and a strong emphasis on research and development. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of new technologies, enhancing market dynamics. The United States is the primary contributor, with significant investments from key players such as Abbott Laboratories and Thermo Fisher Scientific. The competitive landscape is characterized by rapid technological advancements and a focus on personalized medicine. Canada also plays a vital role, contributing to the market with its robust healthcare system and increasing demand for diagnostic services.

Europe : Emerging Regulatory Frameworks

Europe is the second-largest market for blood testing, holding around 30% of the global share. The region benefits from stringent regulatory frameworks that ensure high-quality standards in medical devices and diagnostics. Increasing awareness of preventive healthcare and the rising incidence of infectious diseases are key drivers of market growth. Countries like Germany and the UK are leading the charge, supported by favorable government initiatives. Germany stands out as a major player, with a strong presence of companies like Siemens Healthineers and Roche Diagnostics. The competitive landscape is marked by collaborations and partnerships aimed at enhancing product offerings. The European market is also witnessing a shift towards point-of-care testing, driven by the need for rapid and accurate diagnostics.

Asia-Pacific : Rapidly Growing Healthcare Sector

Asia-Pacific is an emerging powerhouse in the blood testing market, projected to grow significantly due to increasing healthcare investments and rising awareness of health issues. The region holds about 20% of the global market share, with countries like China and India leading the growth trajectory. The demand for advanced diagnostic solutions is fueled by a growing population and rising incidences of lifestyle-related diseases. China is the largest market in the region, with substantial contributions from local and international players. The competitive landscape is evolving, with companies focusing on innovation and affordability. India is also emerging as a key player, driven by government initiatives aimed at improving healthcare access and quality, thus enhancing the overall market dynamics.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region is characterized by untapped market potential in the blood testing sector, holding approximately 5% of the global market share. The growth is driven by increasing healthcare expenditure, rising awareness of disease prevention, and government initiatives to improve healthcare infrastructure. Countries like South Africa and the UAE are at the forefront, with significant investments in healthcare technology. South Africa is the largest market in the region, supported by a growing demand for diagnostic services. The competitive landscape is gradually evolving, with both local and international players entering the market. The region is witnessing a shift towards more advanced testing methods, driven by the need for accurate and timely diagnostics, which is crucial for effective healthcare delivery.

Key Players and Competitive Insights

The Blood Testing Market is currently characterized by a dynamic competitive landscape, driven by technological advancements, increasing demand for early disease detection, and a growing emphasis on personalized medicine. Major players such as Abbott Laboratories (US), Roche Diagnostics (CH), and Siemens Healthineers (DE) are strategically positioned to leverage these trends. Abbott Laboratories (US) focuses on innovation in point-of-care testing, enhancing accessibility and speed in diagnostics. Roche Diagnostics (CH) emphasizes its robust portfolio in molecular diagnostics, while Siemens Healthineers (DE) is investing heavily in digital transformation and AI integration to streamline laboratory workflows. Collectively, these strategies not only enhance their market presence but also intensify competition, as companies vie for leadership in a rapidly evolving sector. In terms of business tactics, companies are increasingly localizing manufacturing to reduce supply chain vulnerabilities and optimize operational efficiency. The Blood Testing Market appears moderately fragmented, with a mix of established players and emerging companies. This structure allows for diverse competitive strategies, where key players can influence market dynamics through innovation and strategic partnerships. In August 2025, Abbott Laboratories (US) announced the launch of a new portable blood testing device aimed at enhancing patient care in remote areas. This strategic move is significant as it aligns with the growing trend towards decentralized healthcare, potentially expanding Abbott's market share in underserved regions. The device's ability to deliver rapid results could redefine patient management protocols, thereby reinforcing Abbott's commitment to innovation. In September 2025, Roche Diagnostics (CH) unveiled a partnership with a leading tech firm to integrate AI capabilities into its diagnostic platforms. This collaboration is crucial as it not only enhances Roche's product offerings but also positions the company at the forefront of the digital transformation trend in healthcare. By leveraging AI, Roche aims to improve diagnostic accuracy and operational efficiency, which could lead to better patient outcomes and increased market competitiveness. In October 2025, Siemens Healthineers (DE) launched a new cloud-based analytics platform designed to optimize laboratory operations. This initiative reflects Siemens' strategic focus on digitalization, enabling laboratories to harness data for improved decision-making. The platform's introduction is likely to enhance Siemens' competitive edge by providing customers with advanced tools for operational efficiency and cost reduction. As of October 2025, the Blood Testing Market is witnessing a shift towards digitalization, sustainability, and AI integration, which are defining current competitive trends. Strategic alliances are increasingly shaping the landscape, allowing companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is expected to evolve, with a pronounced shift from price-based competition to a focus on technological innovation, supply chain reliability, and enhanced patient care solutions.

Key Companies in the Blood Testing Market include

Industry Developments

Recent developments in the Blood Testing Market indicate significant advancements and increased activities among key companies. Abbott Laboratories and Thermo Fisher Scientific Inc. have introduced innovative blood testing solutions to enhance diagnostic accuracy and speed.

In October 2023, Becton Dickinson and Company announced the expansion of its automation capabilities for blood analysis, aimed at improving operational efficiency. Current affairs reflect a growing demand for rapid diagnostics due to the ongoing evolution of infectious diseases and chronic conditions.

This is pushing companies like Hologic Inc. and Roche Holding AG to invest heavily in Research and Development. Notably, in September 2023, Danaher Corporation completed the acquisition of GE Healthcare’s biomanufacturing business, which bolsters its presence in the healthcare space.

This includes blood testing. Additionally, Siemens Healthineers has expanded its pipeline of advanced analyzers through partnerships focusing on the integration of artificial intelligence. The overall market is witnessing a boost in valuation, driven by technological advancements and strategic collaborations.

Over the past two to three years, companies have reported a significant increase in demand for blood tests, with Mindray Medical International Limited recently highlighting a 25% growth in their testing solutions segment.

Future Outlook

Blood Testing Market Future Outlook

The Blood Testing Market is projected to grow at a 7.15% CAGR from 2025 to 2035, driven by technological advancements, increasing chronic diseases, and rising health awareness.

New opportunities lie in:

<p>Development of portable blood testing devices for home use. Integration of AI-driven analytics for personalized medicine. Expansion of telehealth services incorporating blood testing solutions.</p>

By 2035, the Blood Testing Market is expected to be robust, reflecting substantial growth and innovation.

Market Segmentation

Blood Testing Market Type Outlook

Complete Blood Count
Blood Chemistry Tests
Blood Glucose Tests
Coagulation Tests
Blood Typing Tests

Blood Testing Market Product Outlook

Reagents
Consumables
Instruments
Software

Blood Testing Market End User Outlook

Hospitals
Diagnostic Laboratories
Home Care Settings
Research Institutions

Report Scope

MARKET SIZE 2024	110.49(USD Billion)
MARKET SIZE 2025	118.39(USD Billion)
MARKET SIZE 2035	236.23(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	7.15% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Abbott Laboratories (US), Roche Diagnostics (CH), Siemens Healthineers (DE), Thermo Fisher Scientific (US), Danaher Corporation (US), Becton Dickinson and Company (US), Ortho Clinical Diagnostics (US), Bio-Rad Laboratories (US), Hologic, Inc. (US)
Segments Covered	Test Type, End Users, Product, Regional
Key Market Opportunities	Integration of advanced technologies enhances accuracy and efficiency in the Blood Testing Market.
Key Market Dynamics	Technological advancements and regulatory changes drive innovation and competition in the blood testing market.
Countries Covered	North America, Europe, APAC, South America, MEA